baber/WOPTO huggingface dataset:
Patent DE-69405116-D1 (DE)
Inventor: MUNDILL PAUL HENRY CHARLES
IPC: G01N33/543
Filed: 1994-11-08
Granted: 1997-09-25
Abstract: An assay sample testing device comprises a porous liquid-permeable carrier strip within a casing, the carrier including a detection zone in which an assay result is revealed by specific binding of a detectable material directly or indirectly to a binding agent immobilised in the detection zone, the casing including internal registration means which cooperatively engages with corresponding registration means associated with the carrier, for example a pin and hole, such that said detection zone within the casing is precisely located in relation to the interlocking means on the casing. During manufacture, the corresponding registration means is used to control accurate formation of the detection zone on the carrier, and accurate placement of the carrier within the casing.
Patent DE-69407481-D1 (DE)
Inventor: HYPPAENEN TIMO
IPC: B01J8/38
Filed: 1994-06-07
Granted: 1998-02-05
Abstract: A method and apparatus for treating hot process gases produced in high temperature processes in a circulating fluidized bed reactor. The reactor (10) comprises a mixing chamber (12), a particle separator (16) and a return duct (18) for returning the circulating mass from the particle separator to the mixing chamber. The return opening (24) of the return duct is so arranged that the flow of solids entering the mixing chamber via the opening is directed substantially downwardly. The inlet (22) for hot process gas is so arranged as to allow the hot process gas to flow into the mixing chamber as a substantially upwardly directed solids flow so that the solids flow comes into contact with the gas flow. <IMAGE>
Patent DE-69417417-D1 (DE)
Inventor: LAROCHELLE WILLIAM
IPC: C07K16/46
Filed: 1994-06-24
Granted: 1999-04-29
Abstract: Potent neutralizing monoclonal antibodies to the human  alpha  PDGF receptor ( alpha  PDGFR) and fragments thereof are described. These monoclonal antibodies specifically bind to an epitope on  alpha  PDGFR, inhibits PDGF binding with PDGF, antagonizes PDGF, and does not bind  beta  PDGFR receptor. A hybridoma cell line producing such a monoclonal antibody, methods of in vivo imaging of a pathological conditions and methods of inhibiting the growth of a neoplasia expressing  alpha  PDGFR, which use these monoclonal antibodies are also described. In vitro assays for detecting the presence of  alpha  PDGFR and for evaluating the binding affinity of a test compound are also described.
Patent DE-69417859-D1 (DE)
Inventor: LE-KHAC BI
IPC: C08G18/00
Filed: 1994-12-15
Granted: 1999-05-20
Abstract: Polyurethane foam-supported double metal cyanide (DMC) catalysts are disclosed as useful catalysts for epoxide polymerization. The foam-supported catalysts are easy to prepare, and are more active and show reduced induction periods compared with conventional powdered DMC catalysts. The catalysts of the invention can be recovered from the epoxide polymer products and can be reused to catalyze additional epoxide polymerizations.
Patent DE-69420256-D1 (DE)
Inventor: COLOVRET SUZANNE
IPC: F16K17/30
Filed: 1994-06-10
Granted: 1999-09-30
Abstract: The control valve includes a device fitted into the main gas supply pipe leading to a domestic user's house. Within the cylinder of the device is a cone element (12) sliding under the effect of the gas pressure (Pe). The cone element includes sealing rings, and slides into a section of the casing which tapers to a reduced section at an angle ( alpha ). In extreme pressure conditions, the element may slide against the seating (17) within the casing, shutting off the supply of gas entirely. Normally however it regulates the supply pressure to a value determined by the spring strength (15). <IMAGE>
Patent DE-69426299-D1 (DE)
Inventor: PHAN VAN
IPC: D21H17/07
Filed: 1994-06-17
Granted: 2000-12-21
Abstract: Multi-layered tissue paper webs comprising chemical softener compositions and binder materials are disclosed. The multi-layered tissue webs are useful in the manufacture of soft, absorbent paper products such as facial tissues and/or toilet tissues. The multi-layered tissue paper products contain a chemical softening composition comprising a mixture of a quaternary ammonium compound and a polyhydroxy compound. Preferred quaternary ammonium compounds include dialkyl dimethyl ammonium salts such as di(hydrogenated)tallow dimethyl ammonium chloride, di(hydrogenated)tallow dimethyl ammonium methyl sulfate. Preferred polyhydroxy compounds are selected from the group consisting of glycerol, sorbitols, polyglycerols having a weight average molecular weight of from about 150 to about 800, polyoxyethylene glycols and polyoxypropylene glycols having a weight average molecular weight from about 200 to 4000. The multi-layered tissue paper webs also contain an effective amount of binder materials to control linting and/or to offset the loss in tensile strength, if any, resulting from the use of the chemical softening compositions. The binder materials are selected from the various wet and dry strength additives, and retention aids used in the paper making art. Preferably, the majority of the chemical softening compositions will be disposed on the outer layers of the multi-layered tissue paper products where they are most effective. The binder materials are typically dispersed throughout the multi-layered product to control linting. In other words, the chemical softening compositions and the binder materials can be selectively distributed within the multi-layered tissue paper web to enhance the softness, absorbency, and/or lint resistance of a particular layer or ply.
Patent DE-69426871-D1 (DE)
Inventor: HELLBERG MARK
IPC: A61K31/4525
Filed: 1994-12-07
Granted: 2001-04-19
Abstract: Compounds having both calcium antagonist and antioxidant activity are disclosed. The compounds are useful in preventing or alleviating damage to tissues at the cellular level. Methods of treatment which employ these properties of the compounds and corresponding pharmaceutical compositions are also disclosed.
Patent DE-69427043-D1 (DE)
Inventor: OERNBERG ROLF
IPC: F16C11/02
Filed: 1994-10-19
Granted: 2001-05-10
Abstract: PCT No. PCT/SE94/00979 Sec. 371 Date Apr. 10, 1997 Sec. 102(e) Date Apr. 10, 1997 PCT Filed Oct. 19, 1994 PCT Pub. No. WO96/12896 PCT Pub. Date May 2, 1996First and second construction elements, such as claws of a timber grab, are mounted for relative rotational movement with respect to each other by an axis joint. The axis joint includes a bearing bushing an a bearing shaft. The bearing shaft has inner conical surfaces which cooperate with outer conical surfaces of conical washers which are held in place by a screw and nut. Under the influence of the screw and nut the components of the axis joint are held together so that there is a butt connection. The bearing bushing contains a slide bearing surface with internal resilient sealing lips, and annular openings are provided so that the sealing lips can expand freely upon insertion of the bearing shaft into the sleeve and resiliently abut the bearing shaft. When inoperative the sealing lips have an inner diameter less than the outer diameter of the bearing shaft by about 0.1-1.0 mm.
Patent DE-69511415-D1 (DE)
Inventor: RAIDEL MARIA
IPC: A61F13/15
Filed: 1995-06-24
Granted: 1999-09-16
Abstract: An absorbent pad has a covering layer (9) at the leading side of the absorbent body (2), laid in two or more folds (10) along the length. The absorbent body is of cellulose flocking or a fibre air laid material, with a non-woven covering layer.
Patent DE-69518923-D1 (DE)
Inventor: NELSON KAREN JOY HAMMON
IPC: C23C22/53
Filed: 1995-06-09
Granted: 2000-10-26
Abstract: PCT No. PCT/AU95/00340 Sec. 371 Date Apr. 7, 1997 Sec. 102(e) Date Apr. 7, 1997 PCT Filed Jun. 9, 1995 PCT Pub. No. WO95/34693 PCT Pub. Date Dec. 21, 1995A process for forming a conversion coating on the surface of a metal, including: contacting the metal with an acidic solution containing an oxidant in order to initiate growth of a metal oxide cell structure on the metal surface; contacting the metal with water for a period of time sufficient to thicken the oxide and form a metal oxide containing layer of a desired thickness; and treating the metal with one or more rare earth elements in order to impregnate and substantially seal the metal oxide.
Patent DE-69520791-D1 (DE)
Inventor: GALLINA RENATO
IPC: A43D21/00
Filed: 1995-07-10
Granted: 2001-05-31
Abstract: PCT No. PCT/GB95/01620 Sec. 371 Date Mar. 7, 1997 Sec. 102(e) Date Mar. 7, 1997 PCT Filed Jul. 10, 1995 PCT Pub. No. WO96/01574 PCT Pub. Date Jan. 25, 1996A method of making a sports boot having an upper and a flexible material, an outsole and an insole. The insole having a heel region and forwardly projected portion having an outer edge profile which is stepped inwardly. The lower edges of the upper are folded inwardly and stitched to the inwardly stepped edge profile of the forwardly projecting portion of the insole forming a coplanar assembly of the insole and facing edges, stitching the facing edges to form a boot sub-assembly, applying the boot assembly to a last, folding and securing the lower edges of the upper to the heel region of the insole and securing the outsole to the sub-assembly to complete the formation of the boot.
Patent DE-69529540-D1 (DE)
Inventor: KAYE PAUL HENRY
IPC: G06K19/06
Filed: 1995-03-31
Granted: 2003-03-06
Abstract: A microparticle which is invisible to the naked eye and is marked with a machine readable code. A tagging compound comprising a powder, fluid or gas when mixed with one or more set or sets of microparticles of which each has a predetermined shape representative of a unique code selected from a multiplicity of such codes, such that the presence of the microparticles is undetectable to the naked eye.
Patent DE-69532051-D1 (DE)
Inventor: LANG KO C
IPC: B01J19/32
Filed: 1995-09-11
Granted: 2003-12-04
Abstract: An improved packing body is formed from a strip divided into segments along fold lines. Segments along one side of a medial segment are alternately folded along the fold lines into a stack on the top surface of the medial segment. Segments on the other side of the medial segment are then folded along the fold lines into a stack on the bottom surface of the medial segments. Side segments hingedly connected to the medial or end segments can be folded along the side edges of the stack. Baffle elements can project from the surface of the strip at an angle to the longitudinal axis of the packing body. Tapered strips with a large medial segment disposed to the interior can be folded into a shape approaching spherical.
Patent DE-69610166-D1 (DE)
Inventor: LOCATI GIUSEPPE
IPC: B27N3/02
Filed: 1996-06-19
Granted: 2000-10-12
Abstract: A method of making a substantially lattice-like composite material having a large percentage of open spaces comprises the steps of disposing generally elongate and flexible strips (10) in a randomly-oriented chaotic mass (16); atomizing a liquid bonding substance into the mass (16); carrying out a mass-forming process involving volume reduction to make a lattice-like structure of a large percentage of open spaces, in a desired shape; hardening the bonding substance. Thus a substantially lattice-like material having a high percentage of open spaces is achieved, which is formed of a plurality of generally elongate and flexible strips (10) disposed in a randonly-oriented chaotic mass (16), the strips (10) being bonded to each other at discrete points in the mass (16). This material can be manufactured to advantage starting from waste materials, such as paper and wood chips, and it can be formed into sheets (18) and panels of flat shape or of different conformations to make packages and the like. <IMAGE>
Patent DE-69611848-D1 (DE)
Inventor: OESTERLIND ROLAND JOERGEN
IPC: A61M5/32
Filed: 1996-01-05
Granted: 2001-04-05
Abstract: A medical device includes a hollow needle 6 for piercing the skin of a patient. Prior to use, the needle 6 is located in a housing 22. Means 14 is provided for moving the needle tip 8 outwardly from the housing 22 ready for piercing the patient's skin. After use the means 14 is employed to retract the needle 6 back within the housing 22 to a needle protected position. Further means 28, 28<'> 42 is provided outside the housing 22 which is movable between a first position to allow longitudinal movement of the needle 6 relative to the housing 22 and a second position for preventing such movement. <IMAGE>
Patent DE-69617067-D1 (DE)
Inventor: DURIEZ DOMINIQUE
IPC: B32B5/22
Filed: 1996-01-18
Granted: 2002-01-03
Abstract: Method of making a multi-layer pant (1), partic. part of a vehicle internal bodywork, that has hollow or raised deformations (2) of a set shape in a mould (5, 4, 3). A first insert layer (6) is placed in the mould and covered by a second (7), partic. a textile, and an independently shaped slab of thermoplastic foam (8) is placed between them in positions (9) local to the deformations. The three parts are then pressed in the mould. The thermoplastic foam (8), particularly of polypropylene, is bevelled around its edges prior to insertion.
Patent DE-69632965-D1 (DE)
Inventor: INOUE HAJIME
IPC: H04N7/16
Filed: 1996-12-20
Granted: 2004-08-26
Abstract: A recording system that enables single authorized recordings of protected broadcasts be made. Subsequent unauthorized copies are prohibited by encoding a signal that causes the broadcast to be obscured during playback of the unauthorized copies. A broadcast is encoded to indicate that a single copy is authorized. If a copy is authorized, a control signal is input to the recording device wherein the signal is conditioned for recording and prior to placement of the conditioned signal on the recording medium the copy protect signal is encoded. Thus, if a second copy (which is unauthorized) is made, the copy protect signal will cause the recorded second copy to be obscured making the copy of little value to the unauthorized copier.
Patent DE-69633443-D1 (DE)
Inventor: YU RUEY J
IPC: A61K8/00
Filed: 1996-06-06
Granted: 2004-10-28
Abstract: Alpha hydroxyacid esters and related compounds on topical application induced increased skin thickness due to new biosyntheses of dermal components including glycosaminoglycans, proteoglycans, collagen and elastin. Such dermal effects are desirable and beneficial for topical use and treatment of aging related integumental changes including age spots, skin lines, wrinkles, photoaging and aging skin.
Patent DE-69637313-D1 (DE)
Inventor: CHWALISZ KRISTOF
IPC: A61P15/04
Filed: 1996-03-14
Granted: 2007-12-20
Abstract: The invention describes the regulation of cervical dilatation and extensibility by the use of nitric oxide donors and/or substrates or nitric oxide inhibitors. There can be used either(a) at least one nitric oxide donor and/or substrate for manufacture of a medicament to be administered locally intracervically or intravaginally for induction of cervical ripening or(b) at least one nitric oxide inhibitor for manufacture of a medicament to be administered locally intracervically or intravaginally for treatment of cercvical insufficiency or preterm labor.
Patent DE-69715872-D1 (DE)
Inventor: JANSSON ULF
IPC: E01B29/16
Filed: 1997-07-23
Granted: 2002-10-31
Abstract: Device for laying railway track. When deploying a long rail in the course of tracklaying, it is desirable that the position of the rail relative to the sleeper be controlled and corrected as required. This is achieved if the roller (1) is free to move relative to the base (7), that is, in practice, relative to either the rail and/or the roadbed. This is achieved by mounting the roller (1) in a cradle (2) which is free to pivot in a base (7), the degree of movement of the roller/cradle relative to the base being limited by twin stops (4). The invention is provided with a carrying handle (6) to facilitate its practical use.
Patent DE-69721904-D1 (DE)
Inventor: EPWORTH RICHARD EDWARD
IPC: G02F1/03
Filed: 1997-07-10
Granted: 2003-06-18
Abstract: A control system for an etalon arrangement 4, in an optical transmission system involves applying a dither to a laser 1 upstream of the arrangement, monitoring the output of the arrangement, and using a control means 3 to lock the laser frequency to the etalon arrangement response, or vice versa. The control means operates on the basis of a ratio of derivatives of the monitored output with respect to wavelength, to enable locking to a point on the response curve, independent of power variations. <IMAGE>
Patent DE-69727048-D1 (DE)
Inventor: SLINGSBY W
IPC: B01J41/20
Filed: 1997-02-26
Granted: 2004-02-05
Abstract: Anion-exchange compositions are provided comprising anion-exchange functional groups comprising at least a first and a second nitrogen group, wherein the first nitrogen group is a quaternary amine and the second nitrogen group is selected from the group consisting of primary, secondary, tertiary or quaternary amines. Methods of making and using the compositions are also provided.
Patent DE-69729212-D1 (DE)
Inventor: SCHMIDT T
IPC: F24C3/14
Filed: 1997-08-12
Granted: 2004-06-24
Abstract: An LPG canister connector for a combustion appliance having a flow path from a canister containing liquid fuel and having a cap with outlet means at the upstream end of the flow path, a valve assembly adapted to be connected to the cap and equipped with a conduit adapted to be connected to a combustion appliance at the downstream end of the flow path, and promoters for vaporization of said fuel being located intermediate the ends of the flow path.
Patent DE-69731823-D1 (DE)
Inventor: HIROTA KOHSAKU
IPC: C07D473/30
Filed: 1997-07-03
Granted: 2005-01-05
Abstract: A purine derivative represented by the following general formula (I):   <CHEM>  wherein   R<2> is a hydrogen atom or a hydrocarbon group containing at most 14 carbon atoms; any -CH2- group in said hydrocarbon group may be replaced with a carbonyl group, a sulfonyl group, -O- or -S- when said -CH2- group is not directly attached to the purine ring or is in -CH3 group not directly attached to the purine ring; any =CH2 group may be replaced with =O or =S; C-H group in said hydrocarbon group may be replaced with N, a C-halogen group or a C-CN group when said C-H group is in -CH2-group not directly attached to the purine ring, in -CH3 group not directly attached to the purine ring, in >CH-group not directly attached to the purine ring, in =CH-group not directly attached to the purine ring or in =CH2 group; R<6> is a hydroxyl group, an amino group or an amino group mono- or di-substituted with a hydrocarbon group containing at most 10 carbon atoms; R<8> is a hydroxyl group, a mercapto group, an acyloxy group containing at most 18 carbon atoms or an oxycarbonyloxy group substituted with a hydrocarbon group containing at most 19 carbon atoms; R<9> is a hydrocarbon group containing at most 14 carbon atoms; any -CH2- group in said R<9> may be replaced with a carbonyl group, a sulfonyl group, -O- or -S- when said -CH2- group is not directly attached to the purine ring or is in -CH3 group not directly attached to the purine ring; any =CH2 group may be replaced with =O or =S; C-H group in said R<9> may be replaced with N, a C-halogen group or a C-CN group when said C-H group is in -CH2-group not directly attached to the purine ring, in -CH3 group not directly attached to the purine ring, in >CH-group not directly attached to the purine ring, in =CH-group not directly attached to the purine ring, in =CH2 group or in  IDENTICAL CH group; or its tautomer or pharmaceutically acceptable salts thereof, and an interferon inducer, an anti-virus agent or an anti-cancer agent which comprises said purine derivative or pharmaceutically acceptable salts thereof as an active ingredient.
Patent DE-69738822-D1 (DE)
Inventor: CORY SUZANNE
IPC: C07K16/18
Filed: 1997-03-27
Granted: 2008-08-21
Abstract: The present invention is broadly directed to therapeutic molecules capable of inter alia modulating apoptosis in mammalian cells. The therapeutic molecules of the present invention encompass genetic sequences and chemical entities capable of regulating expression of a novel mammalian gene belonging to the bcl-2 family and which promotes cell survival. The therapeutic molecules of the present invention may have further utility in delaying cell cycle entry. In addition, the present invention extends to chemical entities capable of modulating activity and function of the translation product of said novel gene of the bcl-2 family. The present invention also extends to the translation product of the novel gene of the bcl-2 family and its use in, for example, therapy, diagnosis, antibody generation and as a screening tool for therapeutic molecules capable of modulating physiological cell death or survival and/or modulating cell cycle entry.
Patent DE-69800267-D1 (DE)
Inventor: DESURVIRE EMMANUEL
IPC: H04B10/02
Filed: 1998-06-04
Granted: 2000-09-28
Abstract: The transmission system for soliton signals with wavelength multiplexing an in which the bit times for the different multiplex channels are synchronous at least one point, incorporates an absorbent (61, 6i) which can be saturated at the aforementioned point. The usable spectral window of the absorbent covers the different multiplex channels, and the response time of the absorbent is only a small fraction of the bit time, preferably below 10 per cent.
Patent DE-69802797-D1 (DE)
Inventor: SCROGGIE MICHAEL E
IPC: G06Q30/02
Filed: 1998-09-10
Granted: 2002-01-17
Abstract: Information pertaining to products made by manufacturers and sold to consumers through retailers, is distributed to consumers through a communication network that connects consumer communication nodes to a cooperative network site having an accumulation of information about manufacturer product offers and retailer special deals. A consumer can obtain selected items of this information without knowledge of how to reach the cooperative network site, by simply logging in to a manufacturer network site or to a retailer network site. At a manufacturer site, the consumer can obtain a list of local retailers carrying the manufacturer offers and can then select from among the offers and receive complete details of the selected offers. At a retailer site, the consumer can obtain a list of manufacturer offers available at the retailer stores in the consumer's area, and can then select from among the available offers and receive their complete details. An additional feature of the invention makes use of a consumer "personal page," which is an individualized database in which consumer shopping preferences are defined, both by information that the consumer expressly provides and by the consumer's past shopping activity. Use of the personal page allows the consumer to receive product offers that are more targeted to the individual consumer, thus saving the consumer time and effort. Another embodiment of the invention provides for distribution of a product purchase incentive directly to the consumer in response to his or her selection of an advertising banner displayed on an independent commercial network site. <IMAGE>
Patent DE-69807533-D1 (DE)
Inventor: BIRN VALDEMAR
IPC: F16H55/40
Filed: 1998-10-06
Granted: 2002-10-02
Abstract: V-belt pulley comprising an outer rim (2) provided with at least one V-belt groove (7) formed by turning, said groove (7) having a bottom (9) provided with a plurality of radially through-going and circumferentially interspaced openings (8). The pulley is cast with a rim (2) having a radially inwardly facing surface (4) is provided with a plurality of circumferentially interspaced recesses (5) of such a radial depth that the radially through-going openings are formed by the turning thereof.